There are signs of life at the lower reaches of the market with SkinBioTherapeutics PLC bagging £3 million before expenses via a placing of new stock with investors.
As eye-catching as this was - a small-cap receiving a much-need and comparatively substantial cash infusion from the equity market - the sale price of the new shares also caused followers to sit up.
After some horrendous discounts applied to fundraisers to get them away, it was a relief to see SkinBio had to drop the price by less than 10% to get its cash call away.
Shares in the group, which is developing skin health products, were off 2% at 21p - a purely technical markdown.